{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20150515",
          "submission_public_notes": "Please see <a href=\"https://www.fda.gov/STIC/\">www.fda.gov/STIC</a> for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "39392",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050823s004lbl.pdf",
              "date": "20150521",
              "type": "Label"
            },
            {
              "id": "8343",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/050823Orig1s004ltr.pdf",
              "date": "20150519",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20211020",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "69053",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050823s009lbl.pdf",
              "date": "20211021",
              "type": "Label"
            },
            {
              "id": "69079",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/050823Orig1s009ltr.pdf",
              "date": "20211025",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20190729",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "59506",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/050823Orig1s007ltr.pdf",
              "date": "20190730",
              "type": "Letter"
            },
            {
              "id": "59514",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050823s007lbl.pdf",
              "date": "20190730",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20110613",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "42756",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/050823_ceftazidime_toc.html",
              "date": "20120605",
              "type": "Review"
            },
            {
              "id": "8342",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/050823s000ltr.pdf",
              "date": "20110627",
              "type": "Letter"
            },
            {
              "id": "24351",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/050823Orig1s000SumR.pdf",
              "date": "20120605",
              "type": "Summary Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20140401",
          "review_priority": "STANDARD",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        }
      ],
      "application_number": "NDA050823",
      "sponsor_name": "B BRAUN",
      "products": [
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "CEFTAZIDIME IN DEXTROSE CONTAINER",
          "active_ingredients": [
            {
              "name": "CEFTAZIDIME",
              "strength": "EQ 2GM BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Discontinued"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "CEFTAZIDIME IN DEXTROSE CONTAINER",
          "active_ingredients": [
            {
              "name": "CEFTAZIDIME",
              "strength": "EQ 1GM BASE"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Discontinued"
        }
      ]
    }
  ]
}